BiomeSense provides an integrated platform for gut microbiome analysis, combining an at-home biosensor for continuous monitoring with a cloud-based, AI-powered data analysis system. Users collect longitudinal microbiome data at home, which is securely transmitted to the cloud where AI algorithms identify patterns and track changes over time. The company differentiates itself by offering a low-cost, large-scale hardware-and-software solution designed for clinical trials and consumer health, rather than relying on single-time-point tests. Its goal is to help researchers and product teams use microbiome data to understand health and disease and advance precision medicine.
Company Size
11-50
Company Stage
Seed
Total Funding
$5.4M
Headquarters
Chicago, Illinois
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?